Study
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study ID | Alternative Stable ID | Type |
---|---|---|
EGAS00001005981 | Other |
Study Description
The utility of circulating tumour DNA (ctDNA) for longitudinal tumour monitoring in pancreatic ductal adenocarcinoma (PDAC) has not been explored beyond mutations in the KRAS proto-oncogene. We aim to characterise and track patient-specific somatic ctDNA variants, to assess longitudinal changes in disease burden and explore the landscape of actionable alterations.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00001008593 |
Whole genome sequencing from two resectable patients with pancreatic cancer for both normal and tumour tissue samples; whole exome sequencing from the two resectable patients and five unresectable patients of peripheral blood mononuclear cells and blood plasma (1-5 time points per patient), and whole exome sequencing of plasma samples from three chronic pancreatitis patients.
|
Illumina HiSeq 4000,Illumina NovaSeq 6000 | 34 |
Who archives the data?

Publications
Citations
Retrieving...

Retrieving...
